As of May 27
| +0.0069 / +1.68%|
The 3 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 1.00, with a high estimate of 2.00 and a low estimate of 0.60. The median estimate represents a +139.87% increase from the last price of 0.42.
The current consensus among 5 polled investment analysts is to Hold stock in Orexigen Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.